Welcome back to Stockhouse
Member Sign In

Email or Username:

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Enter your email address:
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

Get our best content in your email.

You are already a member! Please enter your password to sign in.
Quote  |  Bullboard  |  News  |  Opinion  |  Level II  |  Charts  |  Profile  |  Financials  |  Options  |  Price History  |  Analysts  |  Earnings  |  Insiders

Knight Therapeutics Inc. T.GUD

Sector: Healthcare | Sub-Sector: Drug Manufacturers - Specialty & Generic

Knight Therapeutics Inc is a specialty pharmaceutical company. The Company is engaged in developing, acquiring, in-licensing, out-licensing, marketing and distributing pharmaceutical products.
Price: $6.89 | Change: +$0.08 | %Change: +1.17%
Volume: 41,790 | Day High/Low: 6.94/6.77 | 52 Week High/Low: 10.00/4.81
View modes: 
0 stars

RE:Like what i see here

It's exciting to watch a company start from zero. Moving quickly from the venture to the main exchange was unheard of...and goes to show this guy sees no barriers to hold us more
0 stars

Like what i see here

Lots of cash and managment that can deploy wisely good combination have started a position and will keep an eye on the GUD-Knight lol  rate and reply
0 stars

RE:RE:RE:why is this PE ratio so low?

One of the best stock pickers of 2015 has a new article out bullish on TNG which had a big day on Thursday. Check it out for Friday's trading it could pop huge: more
0 stars

Finding Nemo 3 News

Not sure if anyone posted this yet from today.  rate and reply
0 stars

RE:RE:why is this PE ratio so low?

Events such as the one-time earnings from a sale (as MUGMODS noted) is why most analysts will also look at forward earnings, the consensus of which (for 2016) were upgraded yesterday to $0.19 (from $ more
0 stars

RE:why is this PE ratio so low?

Don't expect the PE ratio to stay here. One-time earning on the sale of the voucher has caused that number to look artificially low. This is a new company with little-to-no sales - but they have more
0 stars

why is this PE ratio so low?

I am new here, someone pls tell me?  rate and reply
5 stars

RE:Jason Donville comments on T.GUD

It isn't obvious where he'll use the cash. he is very creative and very to time this guy is a mistake (IMO). Like I've said since day 1 of this stock...I held Paladin as more
0 stars

M. Smedley commets on GUD

15-06-30 BUY Knight Therapeutics GUD-T Michael Smedley He is positive on a very long-term progress of them. In the short term, it has been hit by the more
0 stars

Jason Donville comments on T.GUD

Mr. Donville was on Market Call today and said he would not recommend the stock.  He thinks the company is holding too much cash and he thinks it could be years before Mr. Goodman can deploy it more
5 stars

Don't stop there...there's more news...

MONTREAL, June 26, 2015 /CNW Telbec/ - Extenway Solutions Inc. ("Extenway") (TSXV: EY) is pleased to announce the closing, as of June 26, 2015 (the "Closing Date"), of a secured equipment loan more
5 stars

Knight News After Hours  rate and reply
0 stars

Flower day "where's Waldo"

Remember...I was asking about the execs from Orphan.  One is back with Pro Bono. Also, Knight just struck a deal with Synery Strips, making that relationship stronger.  See the news release more
1 star

RE:RE:Knight & Pro Bono Bio

Knight slowly doing what it can from pdp, prn , now Pro bono..If it could make a deal like this often with debt bearing interest of 10% -or higher plus the equity interest and commercialization more
3 stars

RE:Knight & Pro Bono Bio

Another astute move by GUD. Mr. Jonathan Ross Goodman reports CHIVALROUS KNIGHT DOES PRO BONO Knight Therapeutics Inc. has (1) extended a secured loan of $15-million (U.S.) to Pro Bono Bio more
0 stars

Knight & Pro Bono Bio

MONTREAL, QUEBEC--(Marketwired - June 26, 2015) - Knight Therapeutics Inc. (TSX:GUD) ("Knight" or the "Company"), a leading Canadian specialty pharmaceutical company, announced today that it has ( more
0 stars

Pro Bono Bio deal

MONTREAL, QUEBEC, Jun 26, 2015 (Marketwired via COMTEX) -- Knight Therapeutics Inc. (GUD) ("Knight" or the "Company"), a leading Canadian specialty pharmaceutical company, announced today that it has more
0 stars

holding $7

.  rate and reply
0 stars

RE:Why so quiet?

With the recent acquisitions of trx, there are still a lot of bargain in this sector like Pdp...Knight should start using their cash hoard as M&A activies are heating up, its seems that more
0 stars

Why so quiet?

Too quiet right now. Goodman!  Let's make some noise. Buy me something as an early Christmas gift...would ya?  rate and reply